Literature DB >> 22926697

Current therapeutic strategies for acute kidney injury.

Shigeo Negi1, Takashi Shigematsu.   

Abstract

Acute kidney injury (AKI) is characterized by a rapid decrease in kidney function and increased serum creatinine. The term acute renal failure (ARF) has been applied to such clinical manifestations. Despite several advances in the treatment of ARF, such as pharmacologic treatment and renal replacement therapy (RRT), the mortality rate among patients with ARF has changed little over the past four decades. It is widely recognized that ARF is associated with significantly increased morbidity and mortality especially in critically ill patients with ARF requiring RRT. Therefore, in order to improve outcomes in ARF patients, a new concept of AKI has been proposed. Recently the paradigm shift from ARF to AKI has been received by the research and clinical communities. In this review we will discuss the therapeutic strategies for AKI and focus on its management with an emphasis on RRT.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22926697     DOI: 10.1007/s10157-012-0685-4

Source DB:  PubMed          Journal:  Clin Exp Nephrol        ISSN: 1342-1751            Impact factor:   2.801


  47 in total

Review 1.  Meta-analysis: low-dose dopamine increases urine output but does not prevent renal dysfunction or death.

Authors:  Jan O Friedrich; Neill Adhikari; Margaret S Herridge; Joseph Beyene
Journal:  Ann Intern Med       Date:  2005-04-05       Impact factor: 25.391

2.  Neutrophil gelatinase-associated lipocalin (NGAL) as a biomarker for acute renal injury after cardiac surgery.

Authors:  Jaya Mishra; Catherine Dent; Ridwan Tarabishi; Mark M Mitsnefes; Qing Ma; Caitlin Kelly; Stacey M Ruff; Kamyar Zahedi; Mingyuan Shao; Judy Bean; Kiyoshi Mori; Jonathan Barasch; Prasad Devarajan
Journal:  Lancet       Date:  2005 Apr 2-8       Impact factor: 79.321

Review 3.  Is renal dose dopamine protective or therapeutic? Yes.

Authors:  O V Carcoana; R L Hines
Journal:  Crit Care Clin       Date:  1996-07       Impact factor: 3.598

4.  Acute kidney injury, mortality, length of stay, and costs in hospitalized patients.

Authors:  Glenn M Chertow; Elisabeth Burdick; Melissa Honour; Joseph V Bonventre; David W Bates
Journal:  J Am Soc Nephrol       Date:  2005-09-21       Impact factor: 10.121

5.  Renal ischemia/reperfusion leads to macrophage-mediated increase in pulmonary vascular permeability.

Authors:  A A Kramer; G Postler; K F Salhab; C Mendez; L C Carey; H Rabb
Journal:  Kidney Int       Date:  1999-06       Impact factor: 10.612

Review 6.  Developing a consensus classification system for acute renal failure.

Authors:  John A Kellum; Nathan Levin; Catherine Bouman; Norbert Lameire
Journal:  Curr Opin Crit Care       Date:  2002-12       Impact factor: 3.687

Review 7.  Timing of renal replacement therapy initiation in acute renal failure: a meta-analysis.

Authors:  Victor F Seabra; Ethan M Balk; Orfeas Liangos; Marie Anne Sosa; Miguel Cendoroglo; Bertrand L Jaber
Journal:  Am J Kidney Dis       Date:  2008-06-18       Impact factor: 8.860

Review 8.  Biomarkers for the diagnosis and risk stratification of acute kidney injury: a systematic review.

Authors:  S G Coca; R Yalavarthy; J Concato; C R Parikh
Journal:  Kidney Int       Date:  2007-12-19       Impact factor: 10.612

Review 9.  Treatment of acute renal failure.

Authors:  R A Star
Journal:  Kidney Int       Date:  1998-12       Impact factor: 10.612

10.  Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury.

Authors:  Ravindra L Mehta; John A Kellum; Sudhir V Shah; Bruce A Molitoris; Claudio Ronco; David G Warnock; Adeera Levin
Journal:  Crit Care       Date:  2007       Impact factor: 9.097

View more
  6 in total

1.  Fluid management in pre-eclampsia.

Authors:  John Anthony; Leann K Schoeman
Journal:  Obstet Med       Date:  2013-07-26

2.  Comparison of kidney disease: improving global outcomes and acute kidney injury network criteria for assessing patients in intensive care units.

Authors:  Hibiki Shinjo; Waichi Sato; Enyu Imai; Tomoki Kosugi; Hiroki Hayashi; Kunihiro Nishimura; Kimitoshi Nishiwaki; Yukio Yuzawa; Seiichi Matsuo; Shoichi Maruyama
Journal:  Clin Exp Nephrol       Date:  2013-11-27       Impact factor: 2.801

3.  An RNA interference screen identifies new avenues for nephroprotection.

Authors:  E R Zynda; B Schott; M Babagana; S Gruener; E Wernher; G D Nguyen; M Ebeling; E S Kandel
Journal:  Cell Death Differ       Date:  2015-11-13       Impact factor: 15.828

4.  Microsphere-Based Rapamycin Delivery, Systemic Versus Local Administration in a Rat Model of Renal Ischemia/Reperfusion Injury.

Authors:  Jurjen Zandstra; Marike M van Beuge; Johan Zuidema; Arjen H Petersen; Mark Staal; Luisa F Duque; Sergio Rodriguez; Audrey A R Lathuile; Gert J Veldhuis; Rob Steendam; Ruud A Bank; Eliane R Popa
Journal:  Pharm Res       Date:  2015-05-09       Impact factor: 4.200

5.  Omega-3 fatty acid-derived resolvins and protectins in inflammation resolution and leukocyte functions: targeting novel lipid mediator pathways in mitigation of acute kidney injury.

Authors:  Song Hong; Yan Lu
Journal:  Front Immunol       Date:  2013-01-30       Impact factor: 7.561

6.  Association between chloride-rich versus chloride-restrictive intravenous fluid administration and acute kidney injury in cardiovascular patients in ICU wards.

Authors:  Xudong Wang; Chao Zhang; Guangsu Huang; Dahe Han; Xiaoyan Meng; Yi Guo; Chen Kan
Journal:  Exp Ther Med       Date:  2016-06-06       Impact factor: 2.447

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.